Delcath Systems, Inc.
NASDAQ:DCTHMedical - Devices
Healthcare
$19.24 -1.91%
-$0.23 today
- Market cap
- $669.32M
- Beta
- 0.52
- P/E (TTM)
- 751.4
- EPS (TTM)
- $0.02
52W Low $8.12High $14.48
Volume 0.46M
Average 0.42M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
$22.52M
FY 2025 · Annual
Investing Cash Flow
-$26.59M
FY 2025 · Annual
Financing Cash Flow
$15.05M
FY 2025 · Annual
-61.8% YoYCash Flow Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (25.65M) | (36.51M) | (47.68M) | (26.39M) | 2.7M |
| Depreciation & Amortization | 146K | 132K | 128K | 229K | 349K |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 7.83M | 7.94M | 8.15M | 9.77M | 24.23M |
| Change in Working Capital | (5.76M) | 2.11M | (906K) | (15.52M) | (3.07M) |
| Accounts Receivables | 13K | (322K) | 125K | (10.65M) | (854K) |
| Inventory | (557K) | (587K) | (1.32M) | (3.61M) | (3.32M) |
| Accounts Payables | (1.14M) | 1.8M | (199K) | 479K | 4.77M |
| Other Working Capital | (4.08M) | 1.23M | 492K | (1.74M) | (3.66M) |
| Other Non-Cash Items | 831K | 1.37M | 9.05M | 13.23M | (1.7M) |
| Operating Cash Flow | (22.6M) | (24.95M) | (31.25M) | (18.68M) | 22.52M |
| Capital Expenditures | (143K) | (209K) | (58K) | (559K) | (1.55M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | (19.65M) | (52.45M) | (93.22M) |
| Sales of Investments | 0 | 0 | 0 | 52.03M | 68.17M |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (143K) | (209K) | (19.71M) | (981K) | (26.59M) |
| Debt Repayment | 14.44M | (714K) | (6.31M) | (10.61M) | 0 |
| Common Stock Issued | 3.92M | 10.86M | 23.08M | 7.02M | 21.05M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | (6M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 2.46M | 0 | 35.01M | 43M | 0 |
| Financing Cash Flow | 20.82M | 10.14M | 51.78M | 39.41M | 15.05M |
| Effect of Forex Changes | 122K | (115K) | 56K | (32K) | 68K |
| Net Change in Cash | (1.8M) | (15.13M) | 874K | 19.72M | 11.04M |
| Free Cash Flow | (22.75M) | (25.16M) | (31.31M) | (19.24M) | 20.97M |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income$2.7M
+ D&A$349.0K
+ Stock-Based Comp$24.2M
+ Deferred Tax$0
- Working Capital-$3.1M
- Other Non-Cash-$1.7M
= Operating Cash Flow$22.5M
- Capex-$1.5M
= Free Cash Flow$21.0M
Analysis
FY2025 free cash flow is $21.0M. FCF conversion is 776.6% of net income. Operating cash flow was $22.5M, with capex of -$1.5M. The largest bridge item is Stock-Based Comp at $24.2M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 13, 2026 | |
| SC 13G/A | SC 13G/A filing | Nov 12, 2026 | |
| 8-K | Current report | Nov 9, 2026 | |
| 10-Q | Quarterly report | Nov 9, 2026 | |
| SC 13G | SC 13G filing | Oct 27, 2026 |
Does DCTH generate free cash flow?
Delcath Systems, Inc. (DCTH) generated $20.97M of free cash flow in fiscal 2025.
How much operating cash flow does DCTH produce?
Operating cash flow was $22.52M, before capital expenditures of $1.55M.
Continue the stock analysis
Jump to another research area for this company.